JP2004149521A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004149521A5 JP2004149521A5 JP2003346699A JP2003346699A JP2004149521A5 JP 2004149521 A5 JP2004149521 A5 JP 2004149521A5 JP 2003346699 A JP2003346699 A JP 2003346699A JP 2003346699 A JP2003346699 A JP 2003346699A JP 2004149521 A5 JP2004149521 A5 JP 2004149521A5
- Authority
- JP
- Japan
- Prior art keywords
- salt
- pioglitazone
- solid preparation
- metformin
- preparation according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- HYAFETHFCAUJAY-UHFFFAOYSA-N pioglitazone Chemical compound N1=CC(CC)=CC=C1CCOC(C=C1)=CC=C1CC1C(=O)NC(=O)S1 HYAFETHFCAUJAY-UHFFFAOYSA-N 0.000 claims 24
- 150000003839 salts Chemical class 0.000 claims 18
- 239000007787 solid Substances 0.000 claims 13
- 229960005095 pioglitazone Drugs 0.000 claims 12
- 238000002360 preparation method Methods 0.000 claims 12
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 claims 8
- 229960003105 metformin Drugs 0.000 claims 6
- 229940122355 Insulin sensitizer Drugs 0.000 claims 3
- 238000009472 formulation Methods 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 2
- GHUUBYQTCDQWRA-UHFFFAOYSA-N Pioglitazone hydrochloride Chemical compound Cl.N1=CC(CC)=CC=C1CCOC(C=C1)=CC=C1CC1C(=O)NC(=O)S1 GHUUBYQTCDQWRA-UHFFFAOYSA-N 0.000 claims 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims 2
- 238000007922 dissolution test Methods 0.000 claims 2
- 229960004329 metformin hydrochloride Drugs 0.000 claims 2
- OETHQSJEHLVLGH-UHFFFAOYSA-N metformin hydrochloride Chemical group Cl.CN(C)C(=N)N=C(N)N OETHQSJEHLVLGH-UHFFFAOYSA-N 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 229960002827 pioglitazone hydrochloride Drugs 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000000872 buffer Substances 0.000 claims 1
- 239000007853 buffer solution Substances 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000001103 potassium chloride Substances 0.000 claims 1
- 235000011164 potassium chloride Nutrition 0.000 claims 1
- KVMLCRQYXDYXDX-UHFFFAOYSA-M potassium;chloride;hydrochloride Chemical compound Cl.[Cl-].[K+] KVMLCRQYXDYXDX-UHFFFAOYSA-M 0.000 claims 1
- 239000012085 test solution Substances 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003346699A JP4236553B2 (ja) | 2002-10-07 | 2003-10-06 | 固形製剤 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002294045 | 2002-10-07 | ||
| JP2003346699A JP4236553B2 (ja) | 2002-10-07 | 2003-10-06 | 固形製剤 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008125325A Division JP2008208141A (ja) | 2002-10-07 | 2008-05-12 | 固形製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004149521A JP2004149521A (ja) | 2004-05-27 |
| JP2004149521A5 true JP2004149521A5 (https=) | 2008-06-26 |
| JP4236553B2 JP4236553B2 (ja) | 2009-03-11 |
Family
ID=32064024
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003346699A Expired - Lifetime JP4236553B2 (ja) | 2002-10-07 | 2003-10-06 | 固形製剤 |
| JP2008125325A Pending JP2008208141A (ja) | 2002-10-07 | 2008-05-12 | 固形製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008125325A Pending JP2008208141A (ja) | 2002-10-07 | 2008-05-12 | 固形製剤 |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US9101660B2 (https=) |
| EP (1) | EP1561472B2 (https=) |
| JP (2) | JP4236553B2 (https=) |
| KR (2) | KR20070119095A (https=) |
| CN (1) | CN100427143C (https=) |
| AU (1) | AU2003271103B2 (https=) |
| BR (1) | BR0315082A (https=) |
| CA (1) | CA2501587C (https=) |
| CO (1) | CO5700740A2 (https=) |
| CR (1) | CR7797A (https=) |
| CY (1) | CY1114863T1 (https=) |
| DK (1) | DK1561472T3 (https=) |
| ES (1) | ES2437072T5 (https=) |
| IL (1) | IL167835A (https=) |
| MA (1) | MA27487A1 (https=) |
| MX (1) | MXPA05003668A (https=) |
| NO (1) | NO332993B1 (https=) |
| NZ (2) | NZ552559A (https=) |
| PL (1) | PL219608B1 (https=) |
| PT (1) | PT1561472E (https=) |
| RU (1) | RU2357757C2 (https=) |
| SI (1) | SI1561472T1 (https=) |
| UA (1) | UA80991C2 (https=) |
| WO (1) | WO2004030700A1 (https=) |
| ZA (1) | ZA200503507B (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA05007883A (es) | 2003-01-29 | 2005-09-21 | Takeda Pharmaceutical | Proceso para producir una preparacion recubierta. |
| US7198653B2 (en) | 2003-07-31 | 2007-04-03 | Delavau Llc | Calcium carbonate granulation |
| MXPA06004639A (es) | 2003-10-31 | 2006-06-27 | Takeda Pharmaceutical | Preparacion solida que comprende sensibilizador de insulina, secretagogo de insulina y ester de acidos grasos de polioxietileno sorbitano. |
| CA2562391A1 (en) | 2004-04-14 | 2005-10-27 | Takeda Pharmaceutical Company Limited | Solid pharmaceutical preparation |
| PL1878426T3 (pl) * | 2005-04-26 | 2010-11-30 | Sumitomo Dainippon Pharma Co Ltd | Preparat w formie granulatu zawierający związek biguanidu |
| ZA200805147B (en) * | 2005-12-22 | 2010-05-26 | Takeda Pharmaceutical | Solid preparation |
| KR101220643B1 (ko) * | 2006-08-16 | 2013-01-14 | 알리코제약(주) | 사포그릴레이트 함유 경구투여 형태의 약제 |
| US9138414B1 (en) | 2006-09-15 | 2015-09-22 | Delavau Llc | Calcium supplement having enhanced absorption |
| JP4832271B2 (ja) * | 2006-12-11 | 2011-12-07 | 花王株式会社 | 粉末圧縮錠剤 |
| CN101801351B (zh) * | 2007-07-19 | 2012-12-12 | 武田药品工业株式会社 | 包含阿格列汀和盐酸二甲双胍的固体制剂 |
| US8563500B2 (en) | 2007-09-05 | 2013-10-22 | Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts | Methods and compounds for treating diseases caused by reactive oxygen species |
| CN101417130B (zh) * | 2007-10-22 | 2010-10-06 | 鲁南制药集团股份有限公司 | 一种治疗ⅱ型糖尿病及其并发症的药物组合物 |
| TR200803177A2 (tr) * | 2008-05-06 | 2009-11-23 | Bi̇li̇m İlaç Sanayi̇ Ti̇caret A.Ş. | Antihiperglisemik etkili metformîn - pioglitazon formülasyonu. |
| WO2010084504A2 (en) * | 2008-05-26 | 2010-07-29 | Sun Pharmaceutical Industries Ltd. | A stable, oral solid dosage form |
| US20110009347A1 (en) * | 2009-07-08 | 2011-01-13 | Yin Liang | Combination therapy for the treatment of diabetes |
| TW201138843A (en) | 2009-12-18 | 2011-11-16 | Colgate Palmolive Co | Biguanide preservation of precipitated calcium carbonate |
| US8663661B2 (en) | 2009-12-23 | 2014-03-04 | Ratiopharm Gmbh | Solid pharmaceutical dosage form of ticagrelor |
| US20130217778A1 (en) * | 2010-07-21 | 2013-08-22 | Herman H. Vandenburgh | Methods and compositions for the improvement of skeletal muscle function in a mammal |
| EP2441442A1 (en) | 2010-10-08 | 2012-04-18 | LEK Pharmaceuticals d.d. | A pharmaceutical composition comprising a thiazolidinedione |
| TWI631963B (zh) * | 2011-01-05 | 2018-08-11 | 雷西肯製藥股份有限公司 | 包含鈉－葡萄糖共同輸送體１與２之抑制劑的組合物與應用方法 |
| RU2465896C2 (ru) * | 2011-01-20 | 2012-11-10 | Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") | Фармацевтическая противодиабетическая композиция пролонгированного действия |
| CN105125539A (zh) * | 2015-08-05 | 2015-12-09 | 浙江华海药业股份有限公司 | 吡格列酮二甲双胍片及其制备方法 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69331839T2 (de) | 1992-01-29 | 2002-12-12 | Takeda Chemical Industries, Ltd. | Schnellösliche Tablette und ihre Herstellung |
| TWI238064B (en) | 1995-06-20 | 2005-08-21 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
| PT922464E (pt) * | 1996-07-12 | 2005-07-29 | Daiichi Seiyaku Co | Materiais moldados por compressao rapidamente desintegraveis e processo para a sua producao |
| US6291495B1 (en) | 1997-02-24 | 2001-09-18 | Robert B. Rieveley | Method and composition for the treatment of diabetes |
| US6153632A (en) * | 1997-02-24 | 2000-11-28 | Rieveley; Robert B. | Method and composition for the treatment of diabetes |
| US20020004515A1 (en) * | 1997-06-18 | 2002-01-10 | Smith Stephen Alistair | Treatment of diabetes with thiazolidinedione and metformin |
| ATE355840T1 (de) | 1997-06-18 | 2007-03-15 | Smithkline Beecham Plc | Behandlung der diabetes mit thiazolidindione und metformin |
| GB9715295D0 (en) | 1997-07-18 | 1997-09-24 | Smithkline Beecham Plc | Novel method of treatment |
| JPH1160476A (ja) | 1997-08-25 | 1999-03-02 | Taisho Pharmaceut Co Ltd | 圧縮固形組成物 |
| EP1063973B1 (en) | 1998-03-19 | 2016-11-16 | Bristol-Myers Squibb Company | Biphasic controlled release delivery system for high solubility pharmaceuticals and method |
| ATE291418T1 (de) † | 1998-07-28 | 2005-04-15 | Takeda Pharmaceutical | Leicht zerfallende feste zubereitung |
| US6117451A (en) † | 1998-08-25 | 2000-09-12 | Pharmalogix, Inc. | Direct compression metformin hydrochloride tablets |
| HK1040910B (en) † | 1998-11-12 | 2009-06-26 | Smithkline Beecham Plc | Pharmaceutical composition for modified release of an insulin sensitiser and metformin |
| IL143569A0 (en) | 1998-12-24 | 2002-04-21 | Metabasis Therapeutics Inc | A combination of fbpase inhibitors and insulin sensitizers for the treatment of diabetes |
| WO2000066102A2 (en) | 1999-04-29 | 2000-11-09 | City Of Hope | Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (age's) |
| AR028299A1 (es) * | 1999-09-17 | 2003-05-07 | Novartis Ag | Una composicion farmaceutica que comprende nateglinida, un proceso para su preparacion y el uso de dicha composicion para la preparacion de un medicamento para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con diabetes. |
| US6586438B2 (en) | 1999-11-03 | 2003-07-01 | Bristol-Myers Squibb Co. | Antidiabetic formulation and method |
| AR030920A1 (es) † | 1999-11-16 | 2003-09-03 | Smithkline Beecham Plc | Composiciones farmaceuticas para el tratamiento de la diabetes mellitus y condiciones asociadas con la diabetes mellitus, y procedimientos para preparar dichas composiciones |
| AU1403501A (en) * | 1999-11-16 | 2001-05-30 | Smithkline Beecham Plc | Novel composition and use |
| US6524621B2 (en) * | 2000-05-01 | 2003-02-25 | Aeropharm Technology Inc. | Core formulation |
| US6403121B1 (en) * | 2000-05-01 | 2002-06-11 | Aeropharm Technology Incorporated | Core formulation |
| US6780432B1 (en) | 2000-05-01 | 2004-08-24 | Aeropharm Technology, Inc. | Core formulation |
| JP2001335469A (ja) * | 2000-05-26 | 2001-12-04 | Lion Corp | 固体製剤の製造方法 |
| FR2812547B1 (fr) | 2000-08-04 | 2002-10-31 | Lipha | Composition pharmaceutique comprenant une association metformine et derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete |
| JP2002087965A (ja) * | 2000-09-14 | 2002-03-27 | Lion Corp | 口中崩壊性アスピリン含有錠剤 |
| JP4284017B2 (ja) * | 2000-10-06 | 2009-06-24 | 武田薬品工業株式会社 | 固形製剤 |
| CA2424770A1 (en) * | 2000-10-06 | 2003-04-03 | Takeda Chemical Industries, Ltd. | Solid pharmaceutical preparation |
| UA80393C2 (uk) * | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
| AU2003281181A1 (en) | 2002-07-11 | 2004-02-02 | Takeda Pharmaceutical Company Limited | Process for producing coated preparation |
-
2003
- 2003-06-10 UA UAA200504320A patent/UA80991C2/uk unknown
- 2003-10-06 PL PL376176A patent/PL219608B1/pl unknown
- 2003-10-06 ES ES03751344T patent/ES2437072T5/es not_active Expired - Lifetime
- 2003-10-06 CN CNB2003801044191A patent/CN100427143C/zh not_active Expired - Lifetime
- 2003-10-06 DK DK03751344.7T patent/DK1561472T3/da active
- 2003-10-06 MX MXPA05003668A patent/MXPA05003668A/es active IP Right Grant
- 2003-10-06 WO PCT/JP2003/012781 patent/WO2004030700A1/ja not_active Ceased
- 2003-10-06 NZ NZ552559A patent/NZ552559A/en not_active IP Right Cessation
- 2003-10-06 EP EP03751344.7A patent/EP1561472B2/en not_active Expired - Lifetime
- 2003-10-06 NZ NZ539711A patent/NZ539711A/en not_active IP Right Cessation
- 2003-10-06 BR BR0315082-8A patent/BR0315082A/pt not_active Application Discontinuation
- 2003-10-06 KR KR1020077027585A patent/KR20070119095A/ko not_active Withdrawn
- 2003-10-06 US US10/530,262 patent/US9101660B2/en active Active
- 2003-10-06 CA CA002501587A patent/CA2501587C/en not_active Expired - Lifetime
- 2003-10-06 PT PT37513447T patent/PT1561472E/pt unknown
- 2003-10-06 AU AU2003271103A patent/AU2003271103B2/en not_active Expired
- 2003-10-06 RU RU2005113999/15A patent/RU2357757C2/ru active
- 2003-10-06 SI SI200332322T patent/SI1561472T1/sl unknown
- 2003-10-06 KR KR1020057006007A patent/KR100820609B1/ko not_active Expired - Lifetime
- 2003-10-06 JP JP2003346699A patent/JP4236553B2/ja not_active Expired - Lifetime
-
2005
- 2005-04-03 IL IL167835A patent/IL167835A/en unknown
- 2005-04-19 CR CR7797A patent/CR7797A/es unknown
- 2005-05-03 ZA ZA200503507A patent/ZA200503507B/en unknown
- 2005-05-04 MA MA28258A patent/MA27487A1/fr unknown
- 2005-05-05 CO CO05043503A patent/CO5700740A2/es not_active Application Discontinuation
- 2005-05-06 NO NO20052239A patent/NO332993B1/no not_active IP Right Cessation
-
2008
- 2008-05-12 JP JP2008125325A patent/JP2008208141A/ja active Pending
-
2013
- 2013-12-09 CY CY20131101109T patent/CY1114863T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004149521A5 (https=) | ||
| RU2005113999A (ru) | Твердый препарат | |
| JP2014501780A5 (https=) | ||
| JP2007504212A5 (https=) | ||
| JP2019131596A5 (https=) | ||
| JP2010090168A5 (https=) | ||
| US20080027032A1 (en) | Combinations comprising cox-2 inhibitors and aspirin | |
| JP2018514523A5 (https=) | ||
| JP2005532990A5 (https=) | ||
| JP2010523587A5 (https=) | ||
| JP2006513238A (ja) | 吸湿性薬物を含む非‐吸湿性製剤 | |
| CN104161752B (zh) | 一种维格列汀组合物 | |
| JP2012520883A5 (https=) | ||
| Alayoubi et al. | Development of a taste-masked oral suspension of clindamycin HCl using ion exchange resin Amberlite IRP 69 for use in pediatrics | |
| CN103228618A (zh) | 新化合物及其医药用途 | |
| Jost | Dopamine agonists in the treatment of Parkinson's disease: the show must go on: WH Jost | |
| BR112020003375A2 (pt) | composições de amantadina, preparações das mesmas, e métodos de uso | |
| EP2656856A2 (en) | Tablet formulation comprising levodopa, carbidopa, entacapone providing extended release | |
| JP2009522207A5 (https=) | ||
| CA2565993A1 (en) | Salt of 4-or 5- aminosalicylic acid | |
| JPH01501389A (ja) | ポリペプチド製剤 | |
| JP2011503142A5 (https=) | ||
| Altuntaş | Approach toward diabetes treatment in the elderly | |
| JP2019019112A (ja) | ４−［５−（ピリジン−４−イル）−１ｈ−１，２，４−トリアゾール−３−イル］ピリジン−２−カルボニトリル、又はその塩を含む徐放製剤。 | |
| JP2013536823A5 (https=) |